WO2008106984A3 - Pig model for breast cancer, mitochondria related protein folding disorders and/or epidermolysis bullosa simplex - Google Patents

Pig model for breast cancer, mitochondria related protein folding disorders and/or epidermolysis bullosa simplex Download PDF

Info

Publication number
WO2008106984A3
WO2008106984A3 PCT/DK2008/050057 DK2008050057W WO2008106984A3 WO 2008106984 A3 WO2008106984 A3 WO 2008106984A3 DK 2008050057 W DK2008050057 W DK 2008050057W WO 2008106984 A3 WO2008106984 A3 WO 2008106984A3
Authority
WO
WIPO (PCT)
Prior art keywords
breast cancer
related protein
protein folding
epidermolysis bullosa
modified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/DK2008/050057
Other languages
French (fr)
Other versions
WO2008106984A2 (en
Inventor
Peter Michael Kragh
Lars Axel Bolund
Charlotte Brandt Soerensen
Thomas Juhl Corydon
Niels Gregersen
Peter Bross
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aarhus Universitet
Original Assignee
Aarhus Universitet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aarhus Universitet filed Critical Aarhus Universitet
Priority to EP08715611A priority Critical patent/EP2134848A2/en
Priority to US12/529,816 priority patent/US20100115636A1/en
Priority to CA2717251A priority patent/CA2717251A1/en
Publication of WO2008106984A2 publication Critical patent/WO2008106984A2/en
Publication of WO2008106984A3 publication Critical patent/WO2008106984A3/en
Anticipated expiration legal-status Critical
Priority to US13/592,045 priority patent/US20130150465A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
    • C12N15/877—Techniques for producing new mammalian cloned embryos
    • C12N15/8778—Swine embryos
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A01K2217/052—Animals comprising random inserted nucleic acids (transgenic) inducing gain of function
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/108—Swine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0331—Animal model for proliferative diseases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/90—Vectors containing a transposable element

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Environmental Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The present invention relates to a genetically modified pig as a model for studying breast cancer, mitochondria related protein folding disorders and/or epidermolysis bullosa simplex. The modified pig model displays one or more phenotypes associated with any of said disorders. Disclosed is also a modified pig comprising a modified endogeneous BRCA1 and/or BRCA 2 gene, and/or a modified ornithine transcarbamylase gene, and/or a modified Keratin 14 gene and/or a transcriptional or translational product or part thereof. The invention further relates to methods for producing the modified pig; and methods for evaluating the effect of a therapeutical treatment of breast cancer, mitochondria related protein folding disorders and/or epidermolysis bullosa simplex; methods for screening the efficacy of a pharmaceutical composition; and a method for treatment of a human being suffering from breast cancer, mitochondria related protein folding disorders and/or epidermolysis bullosa simplex are disclosed.
PCT/DK2008/050057 2007-03-07 2008-03-06 Pig model for breast cancer, mitochondria related protein folding disorders and/or epidermolysis bullosa simplex Ceased WO2008106984A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP08715611A EP2134848A2 (en) 2007-03-07 2008-03-06 Pig model for breast cancer, mitochondria related protein folding disorders and/or epidermolysis bullosa simplex
US12/529,816 US20100115636A1 (en) 2007-03-07 2008-03-06 Pig model for breast cancer, mitochondria related protein folding disorders and/or epidermolysis bullosa simplex
CA2717251A CA2717251A1 (en) 2007-03-07 2008-03-06 Pig model for breast cancer, mitochondria related protein folding disorders and/or epidermolysis bullosa simplex
US13/592,045 US20130150465A1 (en) 2007-03-07 2012-08-22 Pig model for breast cancer, mitochondria related protein folding disorders and/or epidermolysis bullosa simplex

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DKPA200700342 2007-03-07
DKPA200700341 2007-03-07
DKPA200700341 2007-03-07
DKPA200700344 2007-03-07
DKPA200700344 2007-03-07
DKPA200700342 2007-03-07

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/592,045 Continuation US20130150465A1 (en) 2007-03-07 2012-08-22 Pig model for breast cancer, mitochondria related protein folding disorders and/or epidermolysis bullosa simplex

Publications (2)

Publication Number Publication Date
WO2008106984A2 WO2008106984A2 (en) 2008-09-12
WO2008106984A3 true WO2008106984A3 (en) 2008-12-31

Family

ID=39592108

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DK2008/050057 Ceased WO2008106984A2 (en) 2007-03-07 2008-03-06 Pig model for breast cancer, mitochondria related protein folding disorders and/or epidermolysis bullosa simplex

Country Status (4)

Country Link
US (2) US20100115636A1 (en)
EP (1) EP2134848A2 (en)
CA (1) CA2717251A1 (en)
WO (1) WO2008106984A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8618352B2 (en) 2007-03-28 2013-12-31 University Of Iowa Research Foundation Transgenic porcine models of cystic fibrosis
AU2008233256B2 (en) * 2007-03-28 2013-06-27 The Curators Of The University Of Missouri Transgenic animal models of disease
US8912386B2 (en) 2007-03-28 2014-12-16 University Of Iowa Research Foundation Transgenic pig model of cystic fibrosis
HK1220323A1 (en) 2013-03-15 2017-05-05 Exemplar Genetics, Llc Animal models of cancer
JP6929527B2 (en) * 2015-03-04 2021-09-01 株式会社ポル・メド・テック Disease model pigs showing stable phenotype and methods for producing them
GB201504124D0 (en) 2015-03-11 2015-04-22 Proqr Therapeutics B V Oligonucleotides
WO2017096218A1 (en) * 2015-12-03 2017-06-08 The Penn State Research Foundation Genomic regions with epigenetic variation that contribute to phenotypic differences in livestock
WO2022204370A1 (en) * 2021-03-24 2022-09-29 Modernatx, Inc. Lipid nanoparticles and polynucleotides encoding ornithine transcarbamylase for the treatment of ornithine transcarbamylase deficiency
CN115807036B (en) * 2022-08-15 2026-02-03 南京启真基因工程有限公司 Method for preparing BRCA2 gene mutation breast cancer model pig nuclear transplantation donor cells and special gene editing system thereof

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999060108A2 (en) * 1998-05-15 1999-11-25 Sri International Transgenic animals produced by homologous sequence targeting
US20020035736A1 (en) * 2000-03-16 2002-03-21 Sharon Erickson HER2-transgenic non-human tumor model
WO2002077027A1 (en) * 2000-03-23 2002-10-03 Curagen Corporation Human stra6-like protein and nucleic acids encoding the same
WO2003064633A1 (en) * 2002-01-11 2003-08-07 Gtc Biotherapeutics, Inc. Method and system for fusion and activation following nuclear transfer in reconstructed embryos
GB2388114A (en) * 2002-04-10 2003-11-05 Peter Maccallum Cancer Inst Methods of diagnosis or prognosis of a BRCA associated disorder
WO2004064768A2 (en) * 2003-01-23 2004-08-05 Agy Therapeutics, Inc. Animal model for alzheimer's disease
WO2007028396A2 (en) * 2005-09-08 2007-03-15 Aarhus Universitet Cell nuclear transfer
WO2007124751A2 (en) * 2006-05-01 2007-11-08 Aarhus Universitet An animal model and a method for producing an animal model

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1377225A (en) * 1999-09-13 2002-10-30 马萨诸塞大学 Cloning pigs using donor cells or nuclei from differentiated cells and production of pluripotent porcine

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999060108A2 (en) * 1998-05-15 1999-11-25 Sri International Transgenic animals produced by homologous sequence targeting
US20020035736A1 (en) * 2000-03-16 2002-03-21 Sharon Erickson HER2-transgenic non-human tumor model
WO2002077027A1 (en) * 2000-03-23 2002-10-03 Curagen Corporation Human stra6-like protein and nucleic acids encoding the same
WO2003064633A1 (en) * 2002-01-11 2003-08-07 Gtc Biotherapeutics, Inc. Method and system for fusion and activation following nuclear transfer in reconstructed embryos
GB2388114A (en) * 2002-04-10 2003-11-05 Peter Maccallum Cancer Inst Methods of diagnosis or prognosis of a BRCA associated disorder
WO2004064768A2 (en) * 2003-01-23 2004-08-05 Agy Therapeutics, Inc. Animal model for alzheimer's disease
WO2007028396A2 (en) * 2005-09-08 2007-03-15 Aarhus Universitet Cell nuclear transfer
WO2007124751A2 (en) * 2006-05-01 2007-11-08 Aarhus Universitet An animal model and a method for producing an animal model

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CAO T, ET AL.: "AN INDUCIBLE MOUSE MODEL FOR EPIDERMOLYSIS BULLOSA SIMPLEX: IMPLICATION FOR GENE THERAPY", THE JOURNAL OF CELL BIOLOGY, vol. 152, no. 3, 2001, pages 651 - 656, XP002500577 *
DATABASE EMBL 1 September 1996 (1996-09-01), XP002488550, Database accession no. Z75667 *
LLOYDS ET AL, ET AL.: "THE BASAL KERATIN NETWORK OF STRATIFIED SQUAMOUS EPITHELIA: DEFINING K15 FUNCTION IN THE ABSENCE OF K14", THE JOURNAL OF CELL BIOLOGY, vol. 129, no. 5, 1995, pages 1329 - 1344, XP002500576 *
PETERS B, ET AL.: "COMPLETE CYTOLYSIS AND NEONATAL LETHALITY IN KERATIN 5 KNOCKOUT MICE REVEALS ITS FUNDAMENTAL ROLE IN SKIN INTEGRITY AND IN EPIDERMOLYSIS BULLOSA SIMPLEX", MOLECULAR BIOLOGY, vol. 12, 2001, pages 1775 - 1789, XP002500578 *
VODICKA PETR ET AL: "The miniature pig as an animal model in biomedical research", ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, NEW YORK ACADEMY OF SCIENCES, NEW YORK, NY, US, vol. 1049, 1 May 2005 (2005-05-01), pages 161 - 171, XP009090232, ISSN: 0077-8923 *

Also Published As

Publication number Publication date
WO2008106984A2 (en) 2008-09-12
US20130150465A1 (en) 2013-06-13
CA2717251A1 (en) 2008-09-12
US20100115636A1 (en) 2010-05-06
EP2134848A2 (en) 2009-12-23

Similar Documents

Publication Publication Date Title
WO2008106984A3 (en) Pig model for breast cancer, mitochondria related protein folding disorders and/or epidermolysis bullosa simplex
WO2008106982A3 (en) Pig model for atherosclerosis
PL2104682T3 (en) Diagnosis and treatment of alzheimer's and other neurodementing diseases
EP2369017B8 (en) Micro-RNA-based methods and compositions for the diagnosis and treatment of colon related diseases
BRPI0911518A2 (en) New Therapeutic Approaches for the Treatment of Alzheimer's Disease and Related Diseases Through Modulation of Cell Stress Response
AU2003293460A1 (en) Novel application of biosensors for diagnosis and treatment of disease
WO2006071778A3 (en) Treatment of parkinson's disease and related disorders using postpartum derived cells
EP3299387A3 (en) Identification of tumor-associated markers for diagnosis and therapy
WO2006084209A3 (en) Rnai expression constructs
EP1926730A4 (en) Novel diazaspiroalkanes and their use for treatment of ccr8 mediated diseases
WO2010048332A3 (en) Compounds for treating ophthalmic diseases and disorders
WO2008002621A3 (en) Benzyl-substituted quinolone m1 receptor positive allosteric modulators
WO2009019534A3 (en) Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
WO2004013310A3 (en) Methods of down regulating target gene expression in vivo by introduction of interfering rna
WO2006108582A3 (en) Human marker genes and agents for diagnosis, treatment and prophylaxis of cardiovascular disorders and artherosclerosis
IL164225A (en) Derivatives of benzensulfonyl - methyl - amino-pyrimidin - 4 - ylamino, pharmaceutical compositions comprising them and their use for the manufacture of medicaments for treating diseases mediated by alpha 4 integrin and a process for their preparation
MX2011008261A (en) Pharmaceutical compositions comprising tgf- î²1 inhibitor peptides.
WO2011107812A3 (en) Stabilized pharmaceutical composition
EP4370131A4 (en) Methods of treating alzheimer's disease
WO2010000089A8 (en) Stat3 and tyk2 as drug targets for neurodegenerative diseases
SI1594500T1 (en) Treatment of bacterial diseases of the respiratory organs by locally applying fluoroquinolones
EP4304457A4 (en) Treatment of parkinson's disease
IL206464A0 (en) Pharmaceutical composition, use of 2-imminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases
ZA200803016B (en) Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4
EP4087654A4 (en) Treatment of alzheimer's disease

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08715611

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 6382/DELNP/2009

Country of ref document: IN

Ref document number: 2008715611

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 12529816

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2717251

Country of ref document: CA